CPhI is set to provide the pharma community with an ideal platform to engage with new value chain stakeholders post-COVID.
Just in time (JIT) manufacturing aims to reduce flow times within manufacturing systems while cutting response times from suppliers and thence to customers. Under favorable circumstances, it’s a helpful tool for a manufacturer’s overarching strategy. With the emergence of additive manufacturing alongside rising software sophistication, JIT’s dominance of supply chain management appeared assured.
And then COVID-19 hit.
MJH Life Sciences sees CPhI’s global event in Milan, Italy as an ideal meeting place to rethink, recalibrate, and retool for the next decade of pharmaceutical manufacturing expansion. The ability to congregate face-to-face is a clear opportunity to build on that sense of community, which is so strong in the pharmaceutical industry. Among the many trends accelerated by the pandemic, the urgent requirement to build multiple additional supply partners into any future proofed supply and distribution chain has become clear. An anticipated vial shortage never became a critical bottleneck, partly because the raw materials themselves failed to arrive. Large companies had leveraged their outsized influence over suppliers—sometimes at the expense of customers, sometimes countries, and sometimes patients. This reinforces the necessity for face-to-face meetings, to rebuild trust, and to reduce hoarding and the threatening implicit bias of regionalism.
Rejoin the pharmaceutical community in Milan to engage with new partners, and to energize a supply chain infrastructure strategy with inherent adaptability and parallel inputs. Celebrate the obvious successes the industry had in meeting the COVID-19 challenge, and re-tool with a new understanding of how best to face common goals—together.
Chris Spivey is editorial director for Pharmaceutical Technology.
Pharmaceutical Technology
eBook: October 2021
Pages: 2
When referring to this article, please cite it as C. Spivey, “Rethinking, Recalibrating, and Retooling," Pharmaceutical Technology eBook (October 2021).
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.